Iron infusion and deposition in the kidney
Related Experiment Video
Updated: May 16, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Ramin Tolouian1, Babak Rajabi, Darius Boman
1Division of Nephrology, Department of Internal Medicine, Paul L Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX 79905, USA. ramin.tolouian.@ttuhsc.edu
Insights
Intravenous ferumoxytol, used for iron deficiency anemia in chronic kidney disease (CKD), showed iron deposition in kidney tissues. Intravenous iron dextran did not exhibit this deposition, suggesting potential differences in renal iron handling.
Area of Science:
- Nephrology
- Hematology
- Pharmacology
Background:
- Parenteral iron therapy is crucial for managing iron deficiency anemia (IDA) in chronic kidney disease (CKD) patients.
- Intravenous iron formulations are commonly used to replete iron stores.
Observation:
- A retrospective case study examined iron staining in renal tissues of two CKD patients post-intravenous iron administration.
- Renal biopsies were performed after ferumoxytol or iron dextran infusion.
Findings:
- Ferumoxytol infusion resulted in curvilinear iron deposition within renal tissue macrophages and interstitium.
- No significant iron deposition was observed in the kidney of a patient who received intravenous iron dextran.
Implications:
- The distinct iron deposition patterns suggest differences in the pharmacokinetic profiles and renal handling of ferumoxytol versus iron dextran.
- Further research is warranted to investigate potential renal toxicity associated with iron-induced oxidant stress in CKD patients, particularly with ferumoxytol use.
Background:
Parenteral iron therapy is the mainstay of treating iron deficiency anemia in chronic kidney disease (CKD) patients.
Methods:
Retrospective case study of iron staining of renal tissues in 2 CKD patients who had received intravenous iron prior to the renal biopsy.
Results:
Following the infusion of ferumoxytol, iron staining of renal biopsy demonstrated blue curvilinear deposition of iron in the tissue macrophages (histocytes) and interstitium of the kidney. Renal iron deposition was not observed in a patient administered intravenous iron dextran.
Conclusion:
We postulate that the higher molecular weight of ferumoxytol and different carbohydrate components may lead to deposition and trapping of the ironcarbohydrate complexes in the reticuloendothelial system of the kidney. Potential renal toxicity from iron induced oxidant stress, especially in patients with underlying chronic kidney disease, merits further investigation.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Imaging Studies VII: Vascular Imaging
Acute Kidney Injury II: Pathophysiology
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
